Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
PRAME
Description:
PRAME is a human protein-coding gene associated with cancer biology and studied as a tumor antigen and diagnostic marker.
Related topics:
Cutaneous Melanoma Detection and Management (19%),
Immunotherapy and Immune Responses (16%),
CAR-T cell therapy research (7%)
Wikidata ID:
wiki/Q18037248
OpenAlex ID:
keywords/prame
Characterization of an Antigen That Is Recognized on a Melanoma Showing Partial HLA Loss by CTL Expressing an NK Inhibitory Receptor
1997
·
Hideyuki Ikeda
, Bernard Lethé
, et al.
·
Immunity
·
825
PDF
Gene expression changes associated with progression and response in chronic myeloid leukemia
2006
·
Jerald P. Radich
, Hongyue Dai
, et al.
·
Proceedings of the National Academy of Sciences
·
622
The Human Tumor Antigen PRAME Is a Dominant Repressor of Retinoic Acid Receptor Signaling
2005
·
Mirjam T. Epping
, Liming Wang
, et al.
·
Cell
·
471
PDF
PRAME Expression in Melanocytic Tumors
2018
·
Cecilia Lezcano
, Achim A. Jungbluth
, et al.
·
The American Journal of Surgical Pathology
·
468
PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma
2016
·
Matthew G. Field
, Christina L. Decatur
, et al.
·
Clinical Cancer Research
·
316
Efficient Identification of Novel Hla-A*0201–Presented Cytotoxic T Lymphocyte Epitopes in the Widely Expressed Tumor Antigen Prame by Proteasome-Mediated Digestion Analysis
2001
·
Jan H. Kessler
, Nico J. Beekman
, et al.
·
The Journal of Experimental Medicine
·
290
PDF
Gene Expression in Wilms’ Tumor Mimics the Earliest Committed Stage in the Metanephric Mesenchymal-Epithelial Transition
2002
·
Chi-Ming Li
, Meirong Guo
, et al.
·
American Journal Of Pathology
·
250
PDF
Intratumor Heterogeneity of Cancer/Testis Antigens Expression in Human Cutaneous Melanoma Is Methylation-Regulated and Functionally Reverted by 5-Aza-2′-deoxycytidine
2004
·
Luca Sigalotti
, Elisabetta Fratta
, et al.
·
Cancer Research
·
235
PDF
Expression of tumor-associated antigens in acute myeloid leukemia: implications for specific immunotherapeutic approaches
2006
·
Jochen Greiner
, Michael Schmitt
, et al.
·
Blood
·
229
The Tumor-Associated Antigen PRAME Is Universally Expressed in High-Stage Neuroblastoma and Associated with Poor Outcome
2004
·
André Oberthuer
, Barbara Hero
, et al.
·
Clinical Cancer Research
·
198
PDF
PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cells
1998
·
Van Baren
, Chambost
, et al.
·
British Journal of Haematology
·
196
PDF
Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies?
1998
·
E Neumann
, A Engelsberg
, et al.
·
PubMed
·
187
Development and validation of a noninvasive 2-gene molecular assay for cutaneous melanoma
2016
·
Pedram Gerami
, Zuxu Yao
, et al.
·
Journal of the American Academy of Dermatology
·
166
PDF
Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability
2005
·
S L Smith
, N L Bowers
, et al.
·
British Journal of Cancer
·
165
PDF
mRNA expression of leukemia‐associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies
2003
·
Jochen Greiner
, Mark Ringhoffer
, et al.
·
International Journal of Cancer
·
147
Identification of a Set of Seven Genes for the Monitoring of Minimal Residual Disease in Pediatric Acute Myeloid Leukemia
2006
·
Daniel Steinbach
, Alexander Schramm
, et al.
·
Clinical Cancer Research
·
142
Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia
2008
·
Katayoun Rezvani
, Agnes S. M. Yong
, et al.
·
Blood
·
139
Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas
2016
·
Matthew G. Field
, Michael A. Durante
, et al.
·
Oncotarget
·
134
PDF
Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid
2009
·
Thierry Passeron
, Julio C. Valencia
, et al.
·
Journal of Clinical Investigation
·
133
Tumor Subtype-Specific Cancer–Testis Antigens as Potential Biomarkers and Immunotherapeutic Targets for Cancers
2013
·
Jun Yao
, Otavia L. Caballero
, et al.
·
Cancer Immunology Research
·
132
The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressed by human myeloma cells
2000
·
Catherine Pellat-Deceunynck
, Marie-Paule Mellerin
, et al.
·
European Journal of Immunology
·
132
PDF
Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes
2010
·
Jan H Kessler
, Selina Khan
, et al.
·
Nature Immunology
·
131
PDF
PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma
2017
·
Gülçin Gezgin
, Sietse J. Luk
, et al.
·
JAMA Ophthalmology
·
130
PDF
PRAME-Specific Allo-HLA–Restricted T Cells with Potent Antitumor Reactivity Useful for Therapeutic T-Cell Receptor Gene Transfer
2011
·
Avital L. Amir
, Dirk M. van der Steen
, et al.
·
Clinical Cancer Research
·
130
Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia
2008
·
Concetta Quintarelli
, Gianpietro Dotti
, et al.
·
Blood
·
130
PDF
Show more works
View as search
Works count:
1,503
Citation count:
22,450
Year
Topic
Type